A little while before I know.
There is "no answer yet" to the question of whether the Omicron variant of the coronavirus which is sweeping the United States and Europe requires a suitable vaccine, the director of the European Medicines Agency said on Tuesday. (EMA).
"Let me stress that there is not yet an answer to the question of whether we will need a suitable vaccine, with a different composition, to fight this variant or any other" Emer Cooke said at a press conference.
Read also Vaccines less effective against the Omicron variant?
What real-life studies say
"We need to have more data on the impact of the variant on the efficacy of approved vaccines, and to gather additional evidence" of the action of current vaccines, to prevent severe or milder forms of the disease. illness as well as hospitalizations and deaths, she added.
A new vaccine has just been validated
Emer Cooke however stressed that with five vaccines and six drugs against Covid-19, "we are in a much stronger position than last year".
"We have a lot of additional tools at our disposal", she added, while the European Union authorized on Monday the use of a fifth vaccine against Covid, that of the American Novavax in the wake green light given by the EMA.
Read also Evusheld, Sotrovimab, Kineret ... what are the treatments authorized against Covid-19?
The new variant of the coronavirus is spreading at lightning speed in the United States where it is now dominant, as well as in Europe, particularly in the United Kingdom.
VIDEO.
Omicron: between containment and restrictions, part of Europe tightens the screw
Some countries have taken strong restrictions as the holidays approach.
For the moment, France relies above all on vaccination, with the establishment of a vaccination pass and the probable extension to children.
